NEUROONE MEDICAL TECHNOLOGIES Corp NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp (Nasdaq: NMTC) is a CNS/neurology/psychiatry medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Evo Cortical and Evo sEEG electrodes (510(k) cleared; Zimmer distributes) | Epilepsy diagnostics | unclear | NA_NON_THERAPEUTIC |
| OneRF Brain Ablation System (510(k) cleared; Zimmer distributes) | Functional neurosurgery / epilepsy | unclear | NA_NON_THERAPEUTIC |
| OneRF TN Ablation System (510(k) cleared; limited market release completed March 2026) | Trigeminal neuralgia | unclear | NA_NON_THERAPEUTIC |
| Spinal cord stimulation (thin-film paddle electrode) | Chronic back pain | unclear | NA_NON_THERAPEUTIC |
| Basivertebral nerve ablation | Lower back pain | unclear | NA_NON_THERAPEUTIC |
| sEEG-based drug / gene / cell therapy delivery device | Brain cancer drug delivery (510(k) being pursued) | device-combination | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other CNS/neurology/psychiatry companies
- Brainsway Ltd. BWAY
- NeuroPace Inc NPCE
- Mobia Medical, Inc. MOBI
- ClearPoint Neuro, Inc. CLPT
- Neuronetics, Inc. STIM
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.